Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Schölkens

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Prostaglandins and Medicine|May 1, 1980
Plasma renin activity and vasodepressor action of prostacyclins with modified omega-side chain in anesthetized ratsB A Schölkens
Prostaglandins and Medicine|November 1, 1978
Antihypertensive effect of prostacyclin (PGI2) in experimental hypertension and its influence on plasma renin activity in ratsB A Schölkens
Arzneimittel-Forschung|January 1, 1978
Influence of somatostatin on blood pressure and plasma renin activity in the ratB A Schölkens
Immunopharmacology|June 1, 1996
Kinins in the cardiovascular systemB A Schölkens
Journal of Cardiovascular Pharmacology|January 1, 1987
Influence of local converting enzyme inhibition on angiotensin and bradykinin effects in ischemic rat heartsW Linz, B A Schölkens
British Journal of Pharmacology|April 1, 1992
A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramiprilW Linz, B A Schölkens
Journal of Cardiovascular Pharmacology|January 1, 1992
Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitorsW Linz, B A Schölkens
Archives Internationales De Pharmacodynamie Et De Therapie|April 1, 1975
Increase of experimental hypertension following inhibition of prostaglandin biosynthesisB A Schölkens, R Steinbach
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1988
Local inhibition of angiotensin II formation and bradykinin degradation in isolated heartsB A Schölkens, W Linz
Clinical Physiology and Biochemistry|January 1, 1990
Cardioprotective effects of ACE inhibitors: experimental proof and clinical perspectivesB A Schölkens, W Linz
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Prostaglandins and Medicine|May 1, 1980
Plasma renin activity and vasodepressor action of prostacyclins with modified omega-side chain in anesthetized ratsB A Schölkens
Prostaglandins and Medicine|November 1, 1978
Antihypertensive effect of prostacyclin (PGI2) in experimental hypertension and its influence on plasma renin activity in ratsB A Schölkens
Arzneimittel-Forschung|January 1, 1978
Influence of somatostatin on blood pressure and plasma renin activity in the ratB A Schölkens
Immunopharmacology|June 1, 1996
Kinins in the cardiovascular systemB A Schölkens
Journal of Cardiovascular Pharmacology|January 1, 1987
Influence of local converting enzyme inhibition on angiotensin and bradykinin effects in ischemic rat heartsW Linz, B A Schölkens
British Journal of Pharmacology|April 1, 1992
A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramiprilW Linz, B A Schölkens
Journal of Cardiovascular Pharmacology|January 1, 1992
Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitorsW Linz, B A Schölkens
Archives Internationales De Pharmacodynamie Et De Therapie|April 1, 1975
Increase of experimental hypertension following inhibition of prostaglandin biosynthesisB A Schölkens, R Steinbach
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1988
Local inhibition of angiotensin II formation and bradykinin degradation in isolated heartsB A Schölkens, W Linz
Clinical Physiology and Biochemistry|January 1, 1990
Cardioprotective effects of ACE inhibitors: experimental proof and clinical perspectivesB A Schölkens, W Linz
Pageof 11